Related Experiment Video
Updated: Aug 10, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
End-of-life care for hematological malignancies: the 'technological imperative' and palliative care
1Department of Religion, School of History, Philosophy, Religion and Classics, University of Queensland, St Lucia, Queensland, Australia.
Abstract:
Recent research indicates that hospice/palliative care practices have not yet been integrated into the care of patients with hematological malignancies. As research in relation to palliative care and hematological malignancies is in its infancy, many of the end-of-life care practices with these diagnostic groups are based on unexamined ideas. The findings presented in this article, which are taken from recent post-doctoral research on hematological malignancies and palliative care, make a contribution to documenting information on what is happening to patients and their families in this area. In particular, the findings provide insights on issues associated with the patient and carer awareness that the patient is dying, understanding of prognosis, and the desire to die at home. Such insights are placed in the context of descriptions of the patients' experience with treatment during the terminal stage.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Continuing Care
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Ethical Issues
Ethical Concerns in Healthcare:
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

